Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost €15.00 Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost quantity Add to cart Category: Articles Tag: Volume 3 Description Description Authors: Janet B. Serle, Jake Radell Related products Molecular differences in segmental regions of the trabecular meshwork €15.00 Add to cart Family studies of primary open-angle glaucoma €15.00 Add to cart Special consideration for pediatric glaucoma €15.00 Add to cart The microenvironment of subconjunctival tissue after glaucoma filtration surgery €15.00 Add to cart